GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Cambridge Nutritional Sciences PLC (FRA:RVKA) » Definitions » Piotroski F-Score

Cambridge Nutritional Sciences (FRA:RVKA) Piotroski F-Score : 5 (As of Jun. 09, 2024)


View and export this data going back to 2020. Start your Free Trial

What is Cambridge Nutritional Sciences Piotroski F-Score?

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Cambridge Nutritional Sciences has an F-score of 5 indicating the company's financial situation is typical for a stable company.

The historical rank and industry rank for Cambridge Nutritional Sciences's Piotroski F-Score or its related term are showing as below:

FRA:RVKA' s Piotroski F-Score Range Over the Past 10 Years
Min: 2   Med: 5   Max: 8
Current: 5

During the past 13 years, the highest Piotroski F-Score of Cambridge Nutritional Sciences was 8. The lowest was 2. And the median was 5.


Cambridge Nutritional Sciences Piotroski F-Score Historical Data

The historical data trend for Cambridge Nutritional Sciences's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cambridge Nutritional Sciences Piotroski F-Score Chart

Cambridge Nutritional Sciences Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Piotroski F-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.00 4.00 2.00 3.00 5.00

Cambridge Nutritional Sciences Semi-Annual Data
Mar14 Sep14 Mar15 Sep15 Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23
Piotroski F-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 3.00 - 5.00 -

Competitive Comparison of Cambridge Nutritional Sciences's Piotroski F-Score

For the Medical Instruments & Supplies subindustry, Cambridge Nutritional Sciences's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cambridge Nutritional Sciences's Piotroski F-Score Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Cambridge Nutritional Sciences's Piotroski F-Score distribution charts can be found below:

* The bar in red indicates where Cambridge Nutritional Sciences's Piotroski F-Score falls into.


How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar23) TTM:Last Year (Mar22) TTM:
Net Income was €-4.38 Mil.
Cash Flow from Operations was €-3.57 Mil.
Revenue was €8.55 Mil.
Gross Profit was €4.02 Mil.
Average Total Assets from the begining of this year (Mar22)
to the end of this year (Mar23) was (21.336 + 16.328) / 2 = €18.832 Mil.
Total Assets at the begining of this year (Mar22) was €21.34 Mil.
Long-Term Debt & Capital Lease Obligation was €0.02 Mil.
Total Current Assets was €9.40 Mil.
Total Current Liabilities was €2.19 Mil.
Net Income was €-13.56 Mil.

Revenue was €10.22 Mil.
Gross Profit was €6.10 Mil.
Average Total Assets from the begining of last year (Mar21)
to the end of last year (Mar22) was (34.423 + 21.336) / 2 = €27.8795 Mil.
Total Assets at the begining of last year (Mar21) was €34.42 Mil.
Long-Term Debt & Capital Lease Obligation was €0.09 Mil.
Total Current Assets was €12.85 Mil.
Total Current Liabilities was €4.12 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Cambridge Nutritional Sciences's current Net Income (TTM) was -4.38. ==> Negative ==> Score 0.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Cambridge Nutritional Sciences's current Cash Flow from Operations (TTM) was -3.57. ==> Negative ==> Score 0.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Mar22)
=-4.375/21.336
=-0.20505249

ROA (Last Year)=Net Income/Total Assets (Mar21)
=-13.558/34.423
=-0.39386457

Cambridge Nutritional Sciences's return on assets of this year was -0.20505249. Cambridge Nutritional Sciences's return on assets of last year was -0.39386457. ==> This year is higher. ==> Score 1.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

Cambridge Nutritional Sciences's current Net Income (TTM) was -4.38. Cambridge Nutritional Sciences's current Cash Flow from Operations (TTM) was -3.57. ==> -3.57 > -4.38 ==> CFROA > ROA ==> Score 1.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Mar23)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Mar22 to Mar23
=0.022/18.832
=0.00116822

Gearing (Last Year: Mar22)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Mar21 to Mar22
=0.089/27.8795
=0.00319231

Cambridge Nutritional Sciences's gearing of this year was 0.00116822. Cambridge Nutritional Sciences's gearing of last year was 0.00319231. ==> This year is lower or equal to last year. ==> Score 1.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Mar23)=Total Current Assets/Total Current Liabilities
=9.402/2.193
=4.2872777

Current Ratio (Last Year: Mar22)=Total Current Assets/Total Current Liabilities
=12.847/4.121
=3.11744722

Cambridge Nutritional Sciences's current ratio of this year was 4.2872777. Cambridge Nutritional Sciences's current ratio of last year was 3.11744722. ==> This year's current ratio is higher. ==> Score 1.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

Cambridge Nutritional Sciences's number of shares in issue this year was 231.839. Cambridge Nutritional Sciences's number of shares in issue last year was 186.998. ==> There is larger number of shares in issue this year. ==> Score 0.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=4.018/8.553
=0.46977669

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=6.104/10.215
=0.59755262

Cambridge Nutritional Sciences's gross margin of this year was 0.46977669. Cambridge Nutritional Sciences's gross margin of last year was 0.59755262. ==> Last year's gross margin is higher ==> Score 0.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Mar22)
=8.553/21.336
=0.40087177

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Mar21)
=10.215/34.423
=0.29674927

Cambridge Nutritional Sciences's asset turnover of this year was 0.40087177. Cambridge Nutritional Sciences's asset turnover of last year was 0.29674927. ==> This year's asset turnover is higher. ==> Score 1.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=0+0+1+1+1+1+0+0+1
=5

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Cambridge Nutritional Sciences has an F-score of 5 indicating the company's financial situation is typical for a stable company.

Cambridge Nutritional Sciences  (FRA:RVKA) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


Cambridge Nutritional Sciences Piotroski F-Score Related Terms

Thank you for viewing the detailed overview of Cambridge Nutritional Sciences's Piotroski F-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Cambridge Nutritional Sciences (FRA:RVKA) Business Description

Traded in Other Exchanges
Address
One Fleet Place, London, GBR, EC4M 7WS
Cambridge Nutritional Sciences PLC is a specialist medical diagnostics company focused on promoting a personalized and functional approach to health and nutrition. The company develops, manufacture and market pioneering diagnostic products associated with food sensitivity and gut health. These products enable healthcare practitioners to make informed decisions that can transform their patients' long-term health.

Cambridge Nutritional Sciences (FRA:RVKA) Headlines

No Headlines